Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-04-30
DOI
10.1093/neuonc/noz078
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI)
- (2018) Robert J. Harris et al. MAGNETIC RESONANCE IN MEDICINE
- Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T
- (2018) Daniel Paech et al. NEURO-ONCOLOGY
- Brain hypoxia mapping in acute stroke: Back-to-back T2′ MR versus 18F-fluoromisonidazole PET in rodents
- (2017) Ulf Jensen-Kondering et al. International Journal of Stroke
- Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI
- (2017) Shanshan Jiang et al. MAGNETIC RESONANCE IN MEDICINE
- In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma
- (2017) Mohammed Khurshed et al. Oncotarget
- QuPath: Open source software for digital pathology image analysis
- (2017) Peter Bankhead et al. Scientific Reports
- Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas
- (2016) Jun-Rui Chen et al. MEDICINE
- Simulation, phantom validation, and clinical evaluation of fast pH-weighted molecular imaging using amine chemical exchange saturation transfer echo planar imaging (CEST-EPI) in glioma at 3 T
- (2016) Robert J. Harris et al. NMR IN BIOMEDICINE
- pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRI
- (2015) Robert J. Harris et al. NEURO-ONCOLOGY
- Isocitrate dehydrogenase mutations in gliomas
- (2015) Matthew S. Waitkus et al. NEURO-ONCOLOGY
- Relaxation-compensated CEST-MRI at 7 T for mapping of creatine content and pH - preliminary application in human muscle tissuein vivo
- (2015) Eugenia Rerich et al. NMR IN BIOMEDICINE
- Metabolic consequences of oncogenic IDH mutations
- (2015) Seth J. Parker et al. PHARMACOLOGY & THERAPEUTICS
- IDH1/2 mutation status combined with Ki-67 labeling index defines distinct prognostic groups in glioma
- (2015) Ailiang Zeng et al. Oncotarget
- IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma
- (2015) Philipp Kickingereder et al. Scientific Reports
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- IDH1 Mutations Alter Citric Acid Cycle Metabolism and Increase Dependence on Oxidative Mitochondrial Metabolism
- (2014) A. R. Grassian et al. CANCER RESEARCH
- Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation ofIDH
- (2014) J. Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging
- (2014) Seunghyun Lee et al. JOURNAL OF NEURO-ONCOLOGY
- Technical considerations on the validity of blood oxygenation level-dependent-based MR assessment of vascular deoxygenation
- (2014) Nuria M. Hirsch et al. NMR IN BIOMEDICINE
- On the origins of chemical exchange saturation transfer (CEST) contrast in tumors at 9.4 T
- (2014) Junzhong Xu et al. NMR IN BIOMEDICINE
- InverseZ-spectrum analysis for spillover-, MT-, andT1-corrected steady-state pulsed CEST-MRI - application to pH-weighted MRI of acute stroke
- (2014) Moritz Zaiss et al. NMR IN BIOMEDICINE
- Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation
- (2014) Jinlong Shi et al. TUMOR BIOLOGY
- MR-based hypoxia measures in human glioma
- (2013) Vivien Tóth et al. JOURNAL OF NEURO-ONCOLOGY
- Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry
- (2013) A. N. Tran et al. NEURO-ONCOLOGY
- Lactate dehydrogenase A silencing in IDH mutant gliomas
- (2013) Charles Chesnelong et al. NEURO-ONCOLOGY
- Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps Improve Tumor Delineation and Aid Prediction of Survival in a Multicenter Clinical Trial
- (2013) Benjamin M. Ellingson et al. RADIOLOGY
- Probabilistic Radiographic Atlas of Glioblastoma Phenotypes
- (2012) B.M. Ellingson et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Relationship between Tumor Enhancement, Edema,IDH1Mutational Status,MGMTPromoter Methylation, and Survival in Glioblastoma
- (2012) J.A. Carrillo et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- The Definition of Primary and Secondary Glioblastoma
- (2012) H. Ohgaki et al. CLINICAL CANCER RESEARCH
- Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
- (2012) Peppi Koivunen et al. NATURE
- IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo
- (2011) Linda B. C. Bralten et al. ANNALS OF NEUROLOGY
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
- (2011) Wei Xu et al. CANCER CELL
- Blood-Oxygenation-Level-Dependent-(BOLD-) Based R2′MRI Study in Monkey Model of Reversible Middle Cerebral Artery Occlusion
- (2011) Jing Zhang et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin
- (2011) Albert Lai et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
- (2010) Johanna Chiche et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
- (2010) C. Houillier et al. NEUROLOGY
- Early Experience of Translating pH-Weighted MRI to Image Human Subjects at 3 Tesla
- (2010) P. Z. Sun et al. STROKE
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
- (2009) Zhizhong Li et al. CANCER CELL
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1
- (2009) S. Zhao et al. SCIENCE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started